🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Histone PTM Acetyl-methyllysine Marks transcription starts #ChromatinHaiku nature.com/articles/s4158…

Looking for a motivated postdoctoral fellow to lead research involving #prostatecancer #DNAdamage #epigenetics #therapeutics - Join a vibrant team at Center for Prostate Disease Research, ⁦Uniformed Services University⁩ ⁦Walter Reed National Military Medical Center⁩ ⁦NCI CCR GU Malignancies⁩ careers-hjf.icims.com/jobs/3130/post…

Very happy to see our new paper published in Genes & Development! Reduced H3K36me in 20% of HNSCC tumors unlock a critical choice: whether to elevate H3K27me3 or not. Balancing H3K36me and H3K27me is key for therapeutic breakthroughs in H3K36me-deficient cancers shorturl.at/BCGN8

Outdated treatments dominate the landscape of head & neck cancer, but a groundbreaking study by @sylvestercancer Lluis Morey reveals a ray of hope. 🌟 Unveiling the molecular secrets & a targeted approach with olaparib and decitabine. #HeadAndNeckCancer   bit.ly/49h1TPQ

🔬 Sylvester's @LluisMorey investigates histone defects in 20% of head & neck cancers, aiming for #ClinicalTrials. This #research could transform long-standing treatment methods and has broader implications for #cancer therapy. #CancerResearch loom.ly/1wXrMa8

We are profoundly grateful that Dr. Ruth Gottesman, Professor Emerita of Pediatrics at Albert Einstein College of Medicine - Official, has made a transformational gift to #MontefioreEinstein—the largest to any medical school in the country—that ensures no student has to pay tuition again. bit.ly/3wvBj7y

Caeiro, Nakata et al. show that increased H3K27me3 promotes genome instability and susceptibility to PARP inhibitors in H3K36me-deficient head and neck squamous cell carcinoma, highlighting a new therapeutic strategy. Lluis Morey Read more here: ➡️tinyurl.com/gd351408

Researchers show epigenetic landscapes control cancer genome instability and susceptibility to PARP inhibitors For more on how the work presents a Potential New Treatment for Head and Neck Cancers news.med.miami.edu/new-head-and-n… Read the full story Genes & Development ➡️tinyurl.com/gd351408

We just received a fundable score for our 3rd R01! If you are interested in studying epigenetic mechanisms that contribute to therapy-resistant breast cancer, please DM me!😀🍾

The NCI has reaffirmed Sylvester as South Florida’s only NCI-designated cancer center. We are rated “Outstanding!” This achievement recognizes our dedication to transforming cancer care through research and making an impact. #WeAreNCIDesignated #OnlySylvester

I am honored to be recognized on the list of "Inspiring Hispanic/Latinx Scientists" working in the US. Thanks for the nomination, and thanks Tina Termini for leading this #latinxatlas fredhutch.org/en/about/about…

The Wild West of spike-in normalization go.nature.com/3XLUMw3

🚨 Join us for the Sixth Biennial Miami Epigenetics and Cancer Symposium on Nov. 16-17, 2024! Global leaders in cancer epigenetics will share insights & collaborate on advancing #CancerResearch. Co-organizers: Stephen D. Nimer, MD & Dr. Ramin Shiekhattar. Register: loom.ly/oLcF6WQ.

We have postdoc positions open to study epigenetic mechanisms contributing to resistance to chemo+immuno in TNBC, and projects related to epigenetic determinants of neurodevelopmental disorders. Feel free to reach out to me here/via email. Please like and repost!

You are never too senior to work hard & get yourself a nice first author Science paper! 👏🏻👏🏻👏🏻 science.org/doi/10.1126/sc…

Thrilled to share our latest work published in Nature Genetics today: Plasma proteome variation and its genetic determinants in children and adolescents. 🩸#PediatricProteomics #PlasmaProteomics #pQTL nature.com/articles/s4158… 🧵A thread by Lili Niu explains below ⬇️